Estrogen Receptor A-Induced Cholecystokinin Type a Receptor Expression in the Female Mouse Pituitary

Total Page:16

File Type:pdf, Size:1020Kb

Load more

393 Estrogen receptor a-induced cholecystokinin type A receptor expression in the female mouse pituitary Hyun Joon Kim1,2, Mary C Gieske1,3, Susan Hudgins1, Beob Gyun Kim4, Andree Krust5, Pierre Chambon5 and CheMyong Ko1,3 1Division of Clinical and Reproductive Sciences, Department of Clinical Sciences, University of Kentucky, Lexington, Kentucky 40536, USA 2Department of Anatomy and Neurobiology, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju, South Korea Departments of 3Biology and 4Animal Sciences, University of Kentucky, Lexington, Kentucky 40536, USA 5Institut de Genetique et de Biologie Moleculaire et Cellulaire (CNRS, INSERM, ULP, College de France) and Institut Clinique de la Souris, BP10142, 67404 Illkirch-Strasbourg, France (Correspondence should be addressed to C Ko; Email: [email protected]) Abstract Estrogen plays a critical role in inducing LH surge. In the seen in cultured primary anterior pituitary cells, indicating pituitary, estrogen receptor a (ERa) mediates the action of that estrogen directly acts on pituitary cells to induce CCK- estrogen, while the downstream pathway of ERa activation is AR expression. Immunohistological analysis revealed that yet to be elucidated. Here, we report the finding that more than 80% of gonadotrophs express CCK-AR in the cholecystokinin type A receptor (CCK-AR) is an ERa afternoon of proestrus. To test whether CCK-AR mediated downstream gene in the mouse anterior pituitary. In the the sensitizing effect of estrogen in GnRH-induced LH cycling mouse pituitary, the expression of CCK-AR mRNA secretion, primary pituitary cells were primed with estrogen is markedly higher in the afternoon of proestrus compared followed by treatment with GnRH in the presence or absence with metestrus. Both ovariectomy (OVX) and null mutation of lorglumide, a CCK-AR antagonist. While both groups of the ERa gene completely abolish CCK-AR mRNA secreted LH upon GnRH treatment, lorglumide treatment expression. Injection of 17b-estradiol to OVX wild-type significantly decreased LH secretion. Taken together, this mice induces recovery of CCK-AR mRNA expression to study finds CCK-AR to be an ERa downstream gene in the levels observed at proestrus, but no such recovery is induced pituitary and suggests that CCK-AR may play a role in the in OVX ERa knockout mice. The same pattern of estrogen estrogen sensitization of the pituitary response to GnRH. dependency in inducing CCK-AR mRNA expression was Journal of Endocrinology (2007) 195, 393–405 Introduction As a nuclear receptor transcription factor, ERa has been speculated to regulate the expression of molecules involved in It is well established that, among multiple factors that hormone secretion in the gonadotrophs (Naik et al.1985, contribute to the induction of luteinizing hormone (LH) Powers 1986, Sapino et al.1986, Bauer-Dantoin et al.1993, secretion, the ovarian steroid estrogen plays a pivotal role Thomas & Clarke 1997, Kirkpatrick et al.1998, DePasquale by exerting positive feedback to the pituitary (Clarke 2002, 1999, Clarke 2002, Rispoli & Nett 2005). In this regard, it is Christian et al. 2005); however, the process by which interesting that the cholecystokinin (CCK)/CCK type A estrogen controls these events has not been fully under- receptor (CCK-AR) system, a well-known regulatory stood. Estrogen plays its role by modulating the activity of machinery of protein secretion, has been detected in the a and/or b subtypes of estrogen receptors (ERs) in a tissue pituitary and shown to be involved in the LH secretion (Vijayan type-dependent manner. While both ERa and ERb are et al.1979, Vijayan & McCann 1986, Peuranen et al.1995). present in the pituitary, ERa has been shown to be the Furthermore, recently, it has been shown that estrogen via ERa effector of estrogen action in the pituitary (Sanchez-Criado influences the function and expression of the CCK/CCK-AR et al. 2004, 2005). In support of this finding, ERa system in regulating satiety (Geary et al.1994, 1996, 2001). knockout (ERaKO) female mice are completely infertile These findings have led us to hypothesize that as a way of and do not ovulate, while ERbKO mice are fertile regulating LH secretion, estrogen via ERa may modulate (Dupont et al. 2000, Hewitt & Korach 2003). However, CCK/CCK-AR expression in the pituitary. the downstream pathway of ERa activation in the pituitary CCK is a multifunctional peptide, whose action is mediated gonadotroph is not yet known. by two forms of G-protein-coupled receptors, CCK-AR and Journal of Endocrinology (2007) 195, 393–405 DOI: 10.1677/JOE-07-0358 0022–0795/07/0195–393 q 2007 Society for Endocrinology Printed in Great Britain Online version via http://www.endocrinology-journals.org Downloaded from Bioscientifica.com at 09/30/2021 06:58:45AM via free access 394 HJKIMand others . CCK-AR in the female mouse pituitary type B (CCK-BR; Wank 1995, Williams et al.2002). CCK perfusion was performed using 4% neutralized buffered stimulates the secretion of a variety of proteins including paraformaldehyde. After postfixation with the same fixative, digestive enzymes (Sankaran et al.1980, Rossetti et al.1987), tissues were stored in 20% sucrose and later frozen in OCT neuropeptides (Wank 1995, Tirassa et al.1998), and hormones compound (Tissue-Tek, Sakura Finetek, Torrance, CA, USA). (Rossetti et al.1987, Karlsson & Ahren 1992, Peuranen et al. For determination of stages of the estrous cycle, a standard 1995, Andren-Sandberg et al.1999). Since the first cloning of vaginal lavage technique (Becker et al.2005) was applied. After CCK-AR in the pancreatic acinar cells (Sankaran et al.1980), daily vaginal lavages for 2 weeks, mice were killed on proestrus expression of CCK-AR has been reported in multiple cell types or metestrus at 1500 h to collect estrus cycle-specific pituitary including gastric chief cells (Qian et al.1993), smooth muscle tissues. For primary pituitary culture, 10-week-old female mice cells of gastrointestinal tract (Bitar & Makhlouf 1982, Meyer (C57BL/6) were purchased from Harlan Animal Breeding et al.1989), neurons (Skirboll et al.1986), and endocrine cells Center (Harlan, Indianapolis, IN, USA). (Kamilaris et al.1992). In particular, the CCK/CCK-AR system has been implicated in the secretion of pituitary Generation of ERaKO mice hormones including adrenocorticotropic hormone, K K b-endorphin, growth hormone (GH), thyroid-stimulating The generation of ERaKO (ERa / ) mice resulted from a hormone (TSH), prolactin (PRL), and LH (Vijayan et al. cross of male ERaflox/flox with female Zp3cre, a line expressing 1979, Vijayan & McCann 1986, Bondy et al.1989, Kamilaris Cre recombinase specifically in the oocyte. ERaflox/flox mice et al.1992, Mannisto et al.1992, Peuranen et al.1995). possess two loxP sites flanking exon 3 of the ERa gene Here, we report evidence that estrogen induces CCK-AR (Dupont et al.2000). The resulting F1 heterozygote C expression via ERa in the pituitary and CCK-AR activation ERaflox/ Zp3cre was then bred with ERaflox/flox to produce enhances sensitivity of estrogen-primed gonadotrophs to ERaflox/flox Zp3cre. Female ERaflox/flox Zp3cre mice produce K gonadotropin-releasing hormone (GnRH)-stimuli. ERa oocytes due to the deletion of floxed exon in the oocyte. Thus, oocytes fertilized by sperm from ERaflox/flox K males result in progeny that are ERaflox/ . The breeding of K female ERaflox/flox Zp3cre with male ERaflox/ mice Materials and Methods K K produces half of progeny that are ERa / . Genotyping was performed by PCR using ear biopsy DNA. Genomic Reagents DNA was isolated from ear using the Easy-DNA Kit Antibodies for CCK-AR were purchased from Santa Cruz (Invitrogen). A primer set of ERaP1 (50-ttg ccc gat aac aat Biotechnology Inc. (Santa Cruz, CA, USA). Polyclonal aac at-30) and ERaP3 (50-ggc att acc act tct cct ggg agt ct-30) antisera for mouse pituitary hormones (adrenocorticotropin was used to determine whether or not exon 3 had been K hormone (ACTH), GH, PRL, follicle-stimulating hormone deleted (ERa ). The presence of Zp3 Cre recombinase was (FSH), LH, and TSH) were purchased from the National determined using primers Cre-P1 (50-gga cat gtt cag gga tcg Hormone and Pituitary Program (Harbor-UCLA Medical cca ggc g-30) and Cre-P85 (50-gtg aaa cag cat tgc tgt cac tt-30). Center, Torrance, CA, USA). GnRH, 17b-estradiol (E2), CCK-8s, and lorglumide were purchased from Sigma. Primary pituitary cell culture Molecular reagents were purchased from Invitrogen. Cell culture reagents including Dulbecco’s Modified Eagle’s Anterior pituitary lobes were dissected from 10-week-old Medium (DMEM), gentamicin, BSA, HEPES, trypsin, female C57BL/6 mice pituitaries after carbon dioxide trypsin inhibitor, and DNase I were purchased from Sigma. inhalation. Pituitary cells were isolated as described previously Other reagents including ITS (insulin 10 mg/ml, transferin (Kim et al.2000) with minor modification. Briefly, anterior 5.5 mg/ml, sodium selenite 6.7 ng/ml), fungizone, and fetal pituitary lobes were minced into small pieces in serum-free bovine serum were purchased from Gibco-BRL. media, digested with trypsin for 20 min at room temperature, and dispersed in solution containing trypsin inhibitor by repeated sucking and pushing using an 18 G needle and syringe. Animals and treatments After washing, cells were counted and plated onto poly-L- Animal handling procedures were carried out in accordance lysine-coated culture dish that contained medium (20 mM with the University of Kentucky Animal Care and Use HEPES and 0.3% BSA in DMEM) supplemented with 10% Committee. All mice used in this study have a C57BL/6 fetal bovine serum or charcoal-treated fetal bovine serum. Cells genetic background. For ovariectomy (OVX) and estrogen/ were incubated in a humidified incubator at 37 8Cwith5% vehicle treatment, mice were ovariectomized at 45 days of age.
Recommended publications
  • Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells

    Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells

    Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells. M Schalling, … , T Hökfelt, J F Rehfeld J Clin Invest. 1990;86(2):660-669. https://doi.org/10.1172/JCI114758. Research Article In previous studies we have shown that the gene encoding cholecystokinin (CCK) is expressed in spermatogenic cells of several mammalian species. In the present study we show that a gene homologous to the CCK-related hormone, gastrin, is expressed in the human testis. The mRNA hybridizing to a human gastrin cDNA probe in the human testis was of the same size (0.7 kb) as gastrin mRNA in the human antrum. By in situ hybridization the gastrinlike mRNA was localized to seminiferous tubules. Immunocytochemical staining of human testis revealed gastrinlike peptides in the seminiferous tubules primarily at a position corresponding to spermatids and spermatozoa. In ejaculated spermatozoa gastrinlike immunoreactivity was localized to the acrosome. Acrosomal localization could also be shown in spermatids with electron microscopy. Extracts of the human testis contained significant amounts of progastrin, but no bioactive amidated gastrins. In contrast, ejaculated sperm contained mature carboxyamidated gastrin 34 and gastrin 17. The concentration of gastrin in ejaculated human spermatozoa varied considerably between individuals. We suggest that amidated gastrin (in humans) and CCK (in other mammals) are released during the acrosome reaction and that they may be important for fertilization. Find the latest version: https://jci.me/114758/pdf Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells Martin Schalling,* Hhkan Persson,t Markku Pelto-Huikko,*9 Lars Odum,1I Peter Ekman,I Christer Gottlieb,** Tomas Hokfelt,* and Jens F.
  • Human Chorionic Gonadotropin Regulates Gastric Emptying in Ovariectomized Rats

    Human Chorionic Gonadotropin Regulates Gastric Emptying in Ovariectomized Rats

    K-M SEOW, J-L LEE and others hCG and gastric emptying 216:3 307–314 Research Human chorionic gonadotropin regulates gastric emptying in ovariectomized rats Kok-Min Seow1,2,*, Jyun-Lin Lee3,*, Ming-Luen Doong3, Seng-Wong Huang4, Jiann-Loung Hwang1,5, Wei-Ju Huang6, Full-Young Chang7, Low-Tone Ho3,8,9 and Chi-Chang Juan3,9,10 1Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan 2Department of Obstetrics and Gynecology, National Yang-Ming University, Linong Street, Taipei 11221, Taiwan 3Institute of Physiology, National Yang-Ming University, No. 155, Section 2, Linong Street, Taipei 11221, Taiwan 4Department of Surgery, National Yang-Ming University, Linong Street, Taipei 11221, Taiwan 5Department of Obstetrics and Gynecology, Taipei Medical University, Taipei, Taiwan 6Department of Nursing, Hsin Sheng College of Medical Care and Management, Taoyuan, Taiwan 7Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shi-Pai Road, Taipei 11217, Taiwan 8Department of Internal Medicine, Taipei Veterans General Hospital, Shi-Pai Road, Taipei 11217, Taiwan Correspondence 9Department of Education and Medical Research, Taipei Veterans General Hospital, Shi-Pai Road, Taipei 11217, should be addressed to Taiwan C-C Juan 10Department of Education and Research, Taipei City Hospital, Taipei, Taiwan Email *(K-M Seow and J-L Lee contributed equally to this work) [email protected] Abstract Prolongation of gastrointestinal transit resulting in nausea and vomiting in pregnancy (NVP) Key Words Journal of Endocrinology is the most common phenomenon during the first trimester of pregnancy. Increased human " human chorionic chorionic gonadotropin (hCG) concentration during the first trimester is the most likely gonadotropin cause of NVP.
  • 4 Supplementary File

    4 Supplementary File

    Supplemental Material for High-throughput screening discovers anti-fibrotic properties of Haloperidol by hindering myofibroblast activation Michael Rehman1, Simone Vodret1, Luca Braga2, Corrado Guarnaccia3, Fulvio Celsi4, Giulia Rossetti5, Valentina Martinelli2, Tiziana Battini1, Carlin Long2, Kristina Vukusic1, Tea Kocijan1, Chiara Collesi2,6, Nadja Ring1, Natasa Skoko3, Mauro Giacca2,6, Giannino Del Sal7,8, Marco Confalonieri6, Marcello Raspa9, Alessandro Marcello10, Michael P. Myers11, Sergio Crovella3, Paolo Carloni5, Serena Zacchigna1,6 1Cardiovascular Biology, 2Molecular Medicine, 3Biotechnology Development, 10Molecular Virology, and 11Protein Networks Laboratories, International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, 34149, Trieste, Italy 4Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste, Italy 5Computational Biomedicine Section, Institute of Advanced Simulation IAS-5 and Institute of Neuroscience and Medicine INM-9, Forschungszentrum Jülich GmbH, 52425, Jülich, Germany 6Department of Medical, Surgical and Health Sciences, University of Trieste, 34149 Trieste, Italy 7National Laboratory CIB, Area Science Park Padriciano, Trieste, 34149, Italy 8Department of Life Sciences, University of Trieste, Trieste, 34127, Italy 9Consiglio Nazionale delle Ricerche (IBCN), CNR-Campus International Development (EMMA- INFRAFRONTIER-IMPC), Rome, Italy This PDF file includes: Supplementary Methods Supplementary References Supplementary Figures with legends 1 – 18 Supplementary Tables with legends 1 – 5 Supplementary Movie legends 1, 2 Supplementary Methods Cell culture Primary murine fibroblasts were isolated from skin, lung, kidney and hearts of adult CD1, C57BL/6 or aSMA-RFP/COLL-EGFP mice (1) by mechanical and enzymatic tissue digestion. Briefly, tissue was chopped in small chunks that were digested using a mixture of enzymes (Miltenyi Biotec, 130- 098-305) for 1 hour at 37°C with mechanical dissociation followed by filtration through a 70 µm cell strainer and centrifugation.
  • 1 to the Stomach Inhibits Gut-Brain Signalling by the Satiety Hormone Cholecystokinin (CCK)

    1 to the Stomach Inhibits Gut-Brain Signalling by the Satiety Hormone Cholecystokinin (CCK)

    Targeted Expression of Plasminogen Activator Inhibitor (PAI)-1 to the Stomach Inhibits Gut-Brain Signalling by the Satiety Hormone Cholecystokinin (CCK) Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy By Joanne Gamble October 2013 I For Lily, you are the sunshine in my life…. II Table of Contents Figures and tables VII Acknowledgements XI Publications XIII Abstract XIV Chapter 1 ................................................................................................................................ 1 1.1 Overview ........................................................................................................................... 2 1.2 The Gastrointestinal Tract and Digestive Function ...................................................... 4 1.2.1 Distribution, Structure and Biology of Enteroendocrine (EEC) Cells ........................ 5 1.2.2 Luminal Sensing ......................................................................................................... 6 1.3 Energy Homeostasis ......................................................................................................... 7 1.3.1 Gut Hormones ........................................................................................................... 10 1.3.1.1 The Gastrin Family ............................................................................................ 11 1.3.2 PP-fold Family .........................................................................................................
  • Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J

    Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J

    The Open Nutrition Journal, 2009, 3, 5-7 5 Open Access Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J. Tomasik*, Krystyna Sztefko and Zdzislaw Szafran Department of Clinical Biochemistry, University Children`s Hospital, Krakow, Poland Abstract: Background: It is known that the low ambient temperature causes a considerable increase of appetite. The mechanisms underlying the changes of the amounts of the ingested food in relation to the environmental temperature has not been elucidated. The aim of this study was to investigate the effect of the short exposure to low ambient temperature on the plasma concentration of leptin and cholecystokinin. Methods: Sixteen healthy men, mean age 24.6 ± 3.5 years, BMI 22.3 ± 2.3 kg/m2, participated in the study. The concen- trations of plasma CCK and leptin were determined twice – before and after the 30 min. exposure to + 4 °C by using RIA kits. Results: The mean value of CCK concentration before the exposure to low ambient temperature was 1.1 pmol/l, and after the exposure 0.6 pmol/l (p<0.0005 in the paired t-test). The mean values of leptin before exposure (4.7 ± 1.54 μg/l) were also significantly lower than after the exposure (6.4 ± 1.7 μg/l; p<0.0005 in the paired t-test). However no significant cor- relation was found between CCK and leptin concentrations, both before and after exposure to low temperature. Conclusions: It has been known that a fall in the concentration of CCK elicits hunger and causes an increase in feeding activity.
  • Acute Restraint Stress Induces Cholecystokinin Release Via Enteric

    Acute Restraint Stress Induces Cholecystokinin Release Via Enteric

    Neuropeptides 73 (2019) 71–77 Contents lists available at ScienceDirect Neuropeptides journal homepage: www.elsevier.com/locate/npep Acute restraint stress induces cholecystokinin release via enteric apelin T ⁎ Mehmet Bülbüla, , Osman Sinena, Onur Bayramoğlua, Gökhan Akkoyunlub a Department of Physiology, Akdeniz University, Faculty of Medicine, Antalya, Turkey b Department of Histology and Embryology, Akdeniz University, Faculty of Medicine, Antalya, Turkey ARTICLE INFO ABSTRACT Keywords: Stress increases the apelin content in gut, while exogenous peripheral apelin has been shown to induce chole- Apelin cystokinin (CCK) release. The present study was designed to elucidate (i) the effect of acute stress on enteric Restraint stress production of apelin and CCK, (ii) the role of APJ receptors in apelin-induced CCK release depending on the Cholecystokinin nutritional status. CCK levels were assayed in portal vein blood samples obtained from stressed (ARS) and non- APJ receptor stressed (NS) rats previously injected with APJ receptor antagonist F13A or vehicle. Duodenal expressions of Fasting apelin, CCK and APJ receptor were detected by immunohistochemistry. ARS increased the CCK release which was abolished by selective APJ receptor antagonist F13A. The stimulatory effect of ARS on CCK production was only observed in rats fed ad-libitum. Apelin and CCK expressions were upregulated by ARS. In addition to the duodenal I cells, APJ receptor was also detected in CCK-producing myenteric neurons. Enteric apelin appears to regulate the stress-induced changes in GI functions through CCK. Therefore, apelin/APJ receptor systems seem to be a therapeutic target for the treatment of stress-related gastrointestinal disorders. 1. Introduction for APJ in rodents (De Mota et al., 2000; Medhurst et al., 2003).
  • G Protein-Coupled Receptors

    G Protein-Coupled Receptors

    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. British Journal of Pharmacology (2015) 172, 5744–5869 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors Stephen PH Alexander1, Anthony P Davenport2, Eamonn Kelly3, Neil Marrion3, John A Peters4, Helen E Benson5, Elena Faccenda5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5 and CGTP Collaborators 1School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, 2Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 5Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/ 10.1111/bph.13348/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading.
  • G Protein‐Coupled Receptors

    G Protein‐Coupled Receptors

    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website.
  • GPCR/G Protein

    GPCR/G Protein

    Inhibitors, Agonists, Screening Libraries www.MedChemExpress.com GPCR/G Protein G Protein Coupled Receptors (GPCRs) perceive many extracellular signals and transduce them to heterotrimeric G proteins, which further transduce these signals intracellular to appropriate downstream effectors and thereby play an important role in various signaling pathways. G proteins are specialized proteins with the ability to bind the nucleotides guanosine triphosphate (GTP) and guanosine diphosphate (GDP). In unstimulated cells, the state of G alpha is defined by its interaction with GDP, G beta-gamma, and a GPCR. Upon receptor stimulation by a ligand, G alpha dissociates from the receptor and G beta-gamma, and GTP is exchanged for the bound GDP, which leads to G alpha activation. G alpha then goes on to activate other molecules in the cell. These effects include activating the MAPK and PI3K pathways, as well as inhibition of the Na+/H+ exchanger in the plasma membrane, and the lowering of intracellular Ca2+ levels. Most human GPCRs can be grouped into five main families named; Glutamate, Rhodopsin, Adhesion, Frizzled/Taste2, and Secretin, forming the GRAFS classification system. A series of studies showed that aberrant GPCR Signaling including those for GPCR-PCa, PSGR2, CaSR, GPR30, and GPR39 are associated with tumorigenesis or metastasis, thus interfering with these receptors and their downstream targets might provide an opportunity for the development of new strategies for cancer diagnosis, prevention and treatment. At present, modulators of GPCRs form a key area for the pharmaceutical industry, representing approximately 27% of all FDA-approved drugs. References: [1] Moreira IS. Biochim Biophys Acta. 2014 Jan;1840(1):16-33.
  • A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function

    A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function

    The Journal of Neuroscience, July 15, 2000, 20(14):5564–5573 A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function Seema Bhatnagar,2 Victor Viau,1 Alan Chu,1 Liza Soriano,1 Onno C. Meijer,1 and Mary F. Dallman1 1Department of Physiology, University of California at San Francisco, San Francisco, California 94143-0444, and 2Department of Psychology, University of Michigan, Ann Arbor, Michigan 48109 Chronic stress alters hypothalamic-pituitary-adrenal (HPA) re- ceptor antagonist PD 135,158 into the PVTh before restraint in sponses to acute, novel stress. After acute restraint, the posterior control and chronically cold-stressed rats. ACTH responses to division of the paraventricular thalamic nucleus (pPVTh) exhibits restraint stress were augmented by PD 135,158 only in chroni- increased numbers of Fos-expressing neurons in chronically cally stressed rats but not in controls. In addition, CCK-B recep- cold-stressed rats compared with stress-naı¨vecontrols. Further- tor mRNA expression in the pPVTh was not altered by chronic more, lesions of the PVTh augment HPA activity in response to cold stress. We conclude that previous chronic stress specifically novel restraint only in previously stressed rats, suggesting that facilitates the release of CCK into the pPVTh in response to the PVTh is inhibitory to HPA activity but that inhibition occurs acute, novel stress. The CCK is probably secreted from neurons only in chronically stressed rats. In this study, we further exam- in the lateral parabrachial, the periaqueductal gray, and/or the ined pPVTh functions in chronically stressed rats.
  • What Is Pancreatic Polypeptide and What Does It Do?

    What Is Pancreatic Polypeptide and What Does It Do?

    What is Pancreatic Polypeptide and what does it do? This document aims to evaluate current understanding of pancreatic polypeptide (PP), a gut hormone with several functions contributing towards the maintenance of energy balance. Successful regulation of energy homeostasis requires sophisticated bidirectional communication between the gastrointestinal tract and central nervous system (CNS; Williams et al. 2000). The coordinated release of numerous gastrointestinal hormones promotes optimal digestion and nutrient absorption (Chaudhri et al., 2008) whilst modulating appetite, meal termination, energy expenditure and metabolism (Suzuki, Jayasena & Bloom, 2011). The Discovery of a Peptide Kimmel et al. (1968) discovered PP whilst purifying insulin from chicken pancreas (Adrian et al., 1976). Subsequent to extraction of avian pancreatic polypeptide (aPP), mammalian homologues bovine (bPP), porcine (pPP), ovine (oPP) and human (hPP), were isolated by Lin and Chance (Kimmel, Hayden & Pollock, 1975). Following extensive observation, various features of this novel peptide witnessed its eventual classification as a hormone (Schwartz, 1983). Molecular Structure PP is a member of the NPY family including neuropeptide Y (NPY) and peptide YY (PYY; Holzer, Reichmann & Farzi, 2012). These biologically active peptides are characterized by a single chain of 36-amino acids and exhibit the same ‘PP-fold’ structure; a hair-pin U-shaped molecule (Suzuki et al., 2011). PP has a molecular weight of 4,240 Da and an isoelectric point between pH6 and 7 (Kimmel et al., 1975), thus carries no electrical charge at neutral pH. Synthesis Like many peptide hormones, PP is derived from a larger precursor of 10,432 Da (Leiter, Keutmann & Goodman, 1984). Isolation of a cDNA construct, synthesized from hPP mRNA, proposed that this precursor, pre-propancreatic polypeptide, comprised 95 residues (Boel et al., 1984) and is processed to produce three products (Leiter et al., 1985); PP, an icosapeptide containing 20-amino acids and a signal peptide (Boel et al., 1984).
  • Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions

    Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions

    Molecular Pharmacology Fast Forward. Published on June 2, 2020 as DOI: 10.1124/mol.120.119388 This article has not been copyedited and formatted. The final version may differ from this version. File name: Opioid peptides v45 Date: 5/28/20 Review for Mol Pharm Special Issue celebrating 50 years of INRC Five decades of research on opioid peptides: Current knowledge and unanswered questions Lloyd D. Fricker1, Elyssa B. Margolis2, Ivone Gomes3, Lakshmi A. Devi3 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; E-mail: [email protected] 2Department of Neurology, UCSF Weill Institute for Neurosciences, 675 Nelson Rising Lane, San Francisco, CA 94143, USA; E-mail: [email protected] 3Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Annenberg Downloaded from Building, One Gustave L. Levy Place, New York, NY 10029, USA; E-mail: [email protected] Running Title: Opioid peptides molpharm.aspetjournals.org Contact info for corresponding author(s): Lloyd Fricker, Ph.D. Department of Molecular Pharmacology Albert Einstein College of Medicine 1300 Morris Park Ave Bronx, NY 10461 Office: 718-430-4225 FAX: 718-430-8922 at ASPET Journals on October 1, 2021 Email: [email protected] Footnotes: The writing of the manuscript was funded in part by NIH grants DA008863 and NS026880 (to LAD) and AA026609 (to EBM). List of nonstandard abbreviations: ACTH Adrenocorticotrophic hormone AgRP Agouti-related peptide (AgRP) α-MSH Alpha-melanocyte stimulating hormone CART Cocaine- and amphetamine-regulated transcript CLIP Corticotropin-like intermediate lobe peptide DAMGO D-Ala2, N-MePhe4, Gly-ol]-enkephalin DOR Delta opioid receptor DPDPE [D-Pen2,D- Pen5]-enkephalin KOR Kappa opioid receptor MOR Mu opioid receptor PDYN Prodynorphin PENK Proenkephalin PET Positron-emission tomography PNOC Pronociceptin POMC Proopiomelanocortin 1 Molecular Pharmacology Fast Forward.